Icardio.AI
Icardio.AI (iCardio.ai) builds artificial-intelligence software that automates the interpretation of cardiac ultrasound (echocardiography). Its FDA 510(k)-cleared products include EchoMeasure, which identifies cardiac phases and automatically measures anatomical structures to produce comprehensive echo reports, and CardioVision, which automatically detects aortic stenosis and structural heart disease from ultrasound clips (also granted FDA Breakthrough Device Designation). Additional tooling includes EchoCheck image-quality and view classification, quantitative linear and volumetric measurements, qualitative structural-disease analysis, and EchoGPT image-to-text description. The company trains on a database of 200M+ echocardiography images and partners with ultrasound manufacturers, PACS vendors, and healthcare systems, offering API integration into enterprise PACS workflows. Icardio.AI is a Techstars portfolio company.
Icardio.AI is profiled on the APIs.io network. Tagged areas include Company, Healthcare, Artificial Intelligence, Machine Learning, and Cardiology.
Icardio.AI’s developer surface includes signup flow, support, and 4 more developer resources.
Kin Score
Security Posture 1
Authentication, domain security, vulnerability disclosure, and trust-center signals.
Resources
Get Started 2
Portal, sign-up, and the first successful call
Access & Security 1
Authentication, authorization, and security posture
Operate 1
Status, limits, changes, and where to get help
Company 2
The organization behind the API